XML 40 R30.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock Option Plans (Tables)
9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Valuation

The fair value of stock option grants is estimated using the Black-Scholes option-pricing model with the following assumptions:

 

 

 

Black-Scholes Option-
Pricing

 

 

 

September 30,
2022

 

December 31,
2021

 

Risk-free interest rate

 

2.84% - 3.36%

 

0.42% - 1.34%

 

Expected volatility

 

95.63% - 97.45%

 

97.18% - 98.96%

 

Expected dividend yield

 

- %

 

- %

 

Expected life (in years)

 

5.5 - 6.1

 

 

6.1

 

Summary of Option Activity

The table below summarizes stock option activity under the Company’s stock option plans and Inducement Awards:

 

Stock Option Activity

 

 

 

Number of
Shares

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Contractual
Term

 

 

Aggregate
Intrinsic
Value

 

 

 

 

 

 

 

 

 

(in years)

 

 

(in thousands)

 

Outstanding as of December 31, 2021

 

 

1,098,134

 

 

$

5.80

 

 

 

8.76

 

 

$

5,808

 

Granted

 

 

1,074,364

 

 

 

4.11

 

 

 

10.00

 

 

 

(975

)

Exercised

 

 

(385,527

)

 

 

0.10

 

 

 

8.24

 

 

 

6,626

 

Forfeited and expired

 

 

(98,294

)

 

 

7.92

 

 

 

9.34

 

 

 

(113

)

Outstanding as of September 30, 2022

 

 

1,688,677

 

 

 

5.90

 

 

 

8.95

 

 

 

(1,671

)

Options exercisable at September 30, 2022

 

 

415,361

 

 

 

8.98

 

 

 

8.24

 

 

 

(352

)

Summary of RSU Activity

The following table summarizes the movement in the number of Restricted Stock Units (“RSUs”) issued by the Company under the Plans. The table below summarizes activity relating to RSUs for the nine months ended September 30, 2022:

 

RSU Activity

 

 

 

Restricted
Stock Units

 

 

Weighted-
Average
Grant Date
Fair Value

 

Total nonvested units at December 31, 2021

 

$

291,886

 

 

$

9.06

 

Granted

 

 

25,000

 

 

 

2.91

 

Vested

 

 

(127,605

)

 

 

9.04

 

Total nonvested units at September 30, 2022

 

$

189,281

 

 

$

8.36

 

Summary of Stock-Based Compensation Expense

The Company recorded share-based compensation expense in the following expense categories for the three and nine months ended September 30, 2022 and 2021 of its consolidated statements of operations and comprehensive loss (in thousands):

 

Share-Based Compensation

 

 

 

For the Three Months
Ended September 30,

 

 

For the Nine Months
Ended September 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Research and development expenses

 

$

500

 

 

$

1,115

 

 

$

1,446

 

 

$

4,197

 

General and administrative expenses

 

 

946

 

 

 

400

 

 

 

2,870

 

 

 

1,357

 

 

 

$

1,446

 

 

$

1,515

 

 

$

4,316

 

 

$

5,554